Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2013
11/20/2013CN101365767B Polycationic viscoelastic compositions
11/20/2013CN101091755B Medicine for treating tinea disease and skin disease, and preparation method
11/20/2013CN101090900B Process for preparation of high-purity meloxicam and meloxicam potassium salt
11/19/2013US8586775 Therapeutic compounds and methods of use
11/19/2013US8586770 Unsaturated steroid compounds
11/19/2013US8586768 Design, synthesis and functional characterization of rottlerin analogs
11/19/2013US8586762 Process for producing fused imidazole compound, reformatsky reagent in stable form, and process for producing the same
11/19/2013US8586760 Aminothiazole modulators of beta-3-adrenoreceptor
11/19/2013US8586755 Substituted nicotinamides as KCNQ2/3 modulators
11/19/2013US8586751 Nicotinamide compounds useful as kinase modulators
11/19/2013US8586748 2-sulfonylamino-4-heteroaryl butyramide antagonists of CCR10
11/19/2013US8586739 Heterocyclic compounds and their uses
11/19/2013US8586732 Fused heterocyclic compounds as ion channel modulators
11/19/2013US8586705 Macromolecular compounds having controlled stoichiometry
11/19/2013US8586681 Multi-arm block copolymers as drug delivery vehicles
11/19/2013US8586636 Disulfide chemotherapeutic agents and methods of use thereof
11/19/2013US8586634 Therapeutic compounds
11/19/2013US8586633 Ophthalmologic irrigation solutions and method
11/19/2013US8586632 Use of the irritating principal oleocanthal in olive oil, as well as structurally and functionally similar compounds
11/19/2013US8586631 Calcilytic compounds
11/19/2013US8586630 Enhanced bimatoprost ophthalmic solution
11/19/2013US8586629 Composition for the treatment of oxidative stress
11/19/2013US8586627 Honokiol analogs and their use in treating cancers
11/19/2013US8586626 Metabolites of wortmannin analogs and methods of using the same
11/19/2013US8586625 Derivatives of taxol and closely related compounds
11/19/2013US8586624 Thiophene inhibitors of S-nitrosoglutathione reductase
11/19/2013US8586623 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses
11/19/2013US8586621 Anti-parasitic methods and compositions utilizing diindolylmethane-related indoles
11/19/2013US8586620 Substituted indole compounds having NOS inhibitory activity
11/19/2013US8586619 Agents of calcium ion channel modulators
11/19/2013US8586618 Furanone compounds and lactam analogues thereof
11/19/2013US8586617 Aminomethyl-4-imidazoles
11/19/2013US8586616 Benzimidazole derivatives useful as selective androgen receptor modulators (SARMS)
11/19/2013US8586615 Modulators of cystic fibrosis transmembrane conductance regulator
11/19/2013US8586614 Urea glucokinase activators
11/19/2013US8586613 Pyridinium and quinolinium derivatives
11/19/2013US8586612 Piperidinesulfonylureas and -thioureas, their preparation, their use and pharmaceutical compositions comprising them
11/19/2013US8586610 Methods for the administration of iloperidone
11/19/2013US8586609 Aryl-substituted polycyclic amines, method for the production thereof, and use thereof as a medicament
11/19/2013US8586608 Quinazoline derivatives and pharmaceutical compositions containing them
11/19/2013US8586607 Compounds for the treatment of metabolic diseases
11/19/2013US8586606 Heterocyclic compounds with affinity to muscarinic receptors
11/19/2013US8586605 Fused amino pyridine as HSP90 inhibitors
11/19/2013US8586604 Inhibitors of the microsomal prostaglandin E2 synthase-1
11/19/2013US8586603 Aminotetraline derivatives
11/19/2013US8586602 Derivatives of 7 alkynyl-1,8 naphthyridones, preparation method thereof and use of same in therapeutics
11/19/2013US8586601 Stable SNS-595 compositions and methods of preparation
11/19/2013US8586600 Heterocyclic compounds and uses thereof
11/19/2013US8586599 Polymorphic forms of 6-(1-methyl-1H-pyrazol-4-yl)-2-{3-[5-(2-morpholin-4-yl-ethoxy)-pyrimidin-2-yl]-benzyl}-2H-pyridazin-3-one dihydrogenphosphate and processes of manufacturing thereof
11/19/2013US8586598 CDK inhibitor salts
11/19/2013US8586597 6-fluoro-3-phenyl-2-[1-(9H-purin-6-ylamino)ethyl]-3H-quinazolin-4-one as an inhibitor of human phosphatidylinositol 3-kinase delta
11/19/2013US8586596 Compounds as cannabinoid receptor ligands
11/19/2013US8586595 Positron emission tomography imaging method
11/19/2013US8586594 Inhibitors of diacylglycerol O-acyltransferase type 1 enzyme
11/19/2013US8586592 Pharmaceutical formulations comprising voriconazole and processes for preparation thereof
11/19/2013US8586591 Aminopyrazine derivative and medicine
11/19/2013US8586590 Compounds
11/19/2013US8586589 Piperidine and piperazine phenyl sulfonamides as modulators of ion channels
11/19/2013US8586588 Aryl pyridazinone derivatives and their use as H3 receptor ligands
11/19/2013US8586587 Crystalline molecular complex of tadalafil and methylparaben
11/19/2013US8586586 Methods and compositions for treating or preventing erythema
11/19/2013US8586585 Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as Alzheimer's disease, type 2 diabetes and Parkinson's disease
11/19/2013US8586584 Compounds for the treatment of hepatitis C
11/19/2013US8586583 Compounds
11/19/2013US8586582 PI3K/mTOR kinase inhibitors
11/19/2013US8586581 Ethynyl compounds useful for treatment of CNS disorders
11/19/2013US8586580 2,7-substituted thieno[3,2-d] pyrimidine compounds as protein kinase inhibitors
11/19/2013US8586579 Anellated pyridine compounds
11/19/2013US8586578 Deuterated 5,6-dihydro-1H-pyridin-2-one compounds
11/19/2013US8586576 Substituted pyrazolo[1,5-a]pyrimidines as cyclin dependent kinase inhibitors
11/19/2013US8586575 Abuse deterrent and anti-dose dumping pharmaceutical salts useful for the treatment of attention deficit/hyperactivity disorder
11/19/2013US8586574 Benzoxazepin PI3K inhibitor compounds and methods of use
11/19/2013US8586573 N-(Aminoheteroaryl)-1H-indole-2-carboxamide derivatives, and preparation and therapeutic application thereof
11/19/2013US8586572 3-phenyl-azetidine derivatives useful as modulators of cortical catecholaminergic neurotransmission
11/19/2013US8586571 Heterocyclic compound
11/19/2013US8586570 Sox-based kinase sensor
11/19/2013US8586569 Betulonic and betulinic acid derivatives
11/19/2013US8586568 Methods and products for treatment of diseases
11/19/2013US8586567 Concentrated therapeutic phospholipid compositions
11/19/2013US8586566 Unsaturated heterocyclic derivatives
11/19/2013US8586565 Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases
11/19/2013US8586564 Synthetic glycolipid analogues and derivatives for the treatment of pathologic disorders
11/19/2013US8586563 Nutritional composition containing oligosaccharide mixture
11/19/2013US8586562 Fluid compositions for improving skin conditions
11/19/2013US8586561 Anti-tumor agent comprising cytidine derivative and carboplatin
11/19/2013US8586556 Methods, compositions and drug delivery systems for intraocular delivery of siRNA molecules
11/19/2013US8586555 Immunomodulatory compositions, formulations, and methods for use thereof
11/19/2013US8586552 4,6-substituted 2,5-dideoxystreptamine aminoglycoside antibiotics
11/19/2013US8586551 18-membered macrocycles and analogs thereof
11/19/2013US8586550 Thiazole derivatives as SGLT2 inhibitors and pharmaceutical composition comprising same
11/19/2013US8586549 Composition and method for modulating and maintaining vaginal bacterial flora and vaginal acidity
11/19/2013US8586527 Cerivastatin to treat pulmonary disorders
11/19/2013US8586524 Modulators of pharmacological agents
11/19/2013US8586332 Method for producing oligopolysaccharides
11/19/2013US8586317 Methods of diagnosing hypophosphatemic disorders
11/19/2013US8586311 Method of determining a chemotherapeutic regimen based on ERCC1 and TS expression
11/19/2013US8586292 Methods for identifying compounds for treatment of thrombotic condition
11/19/2013US8586291 Mutations in the Bcr-Abl tyrosine kinase associated with resistance to ST1-571
11/19/2013US8586112 Treatment of parasitic infections in humans and animals
11/19/2013US8586098 Loading of hydrophobic drugs into hydrophilic polymer delivery systems
1 ... 490 491 492 493 494 495 496 497 498 499 500 501 502 503 504 505 506 507 508 509 510 ... 7860